维普中文期刊产品整合服务
33篇 您的检索式:作者名="BAUMERT T F"
    题名 作者 年代 出处 被引量
1Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice显示文摘Lacek K Vercauteren K Grzyb K Naddeo M Verhoye L Slowikowski M P Fafi-Kremer S Patel A H Baumert T F Folgori A Leroux-Roels G Cortese R Meuleman P Nicosia A 2012J Hepatol2012,57,1:1
2Monoclonal anti-claudin 1antibodies prevent hepatitis C virus infection of primary human hepatocytes显示文摘Fofana I Krieger S E Grunert F Glauben S Xiao F Fafi-Kremer S Soulier E Royer C Thumann C Mee C J McKeating J A Dragic T Pessaux P Stoll-Keller F Schuster C Thompson J Baumert T F 2010Gastroenterology2010,,:1
3EGFR and EphA2are host factors for hepatitis C virus entry and possible targets for antiviral therapy显示文摘Lupberger J Zeisel M B Xiao F Thumann C Fofana I Zona L Davis C Mee C J Turek M Gorke S Royer C Fischer B Zahid M N Lavillette D Fresquet J Cosset F L Rothenberg S M Pietschmann T Patel A H Pessaux P Doffol M Raffelsbe-rger W Poch O McKeating J A Brino L Baumert T F 2011Nat Med2011,17,5:1
4Synergy of entry inhibitors with direct-Acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C显示文摘Xiao F Fofana I Thumann C Mailly L Alles R Robinet E Meyer N Schaeffer M Habersetzer F Doffol M Leyssen P Neyts J Zeisel M B Baumert T F 2014Gut2014,,:1
5Hepatitis C virus entry:molecular biology and clinical implications显示文摘Barth H Liang T J Baumert T F 2006Hepatology2006,44,3:1
6Uptake and presentation of hepatitis C virus like particles by human dendritic cells显示文摘Barth H Ulsenheimer A Pape G R Diepolder H M Hoffmann M Neumann-Haefelin C Thimme R Henneke P Klein R Paranhos-BaccalàG Depla E Liang T J Blum H E Baumert T F 2005Blood2005,105,9:1
7Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C 显示文摘Baumert T F Rosler C Malim M H 2007Hepatology2007,46,3:1
8Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate 显示文摘Baumert T F Vergalla J Satoi J 1999Gastroenterology1999,117,6:1
9Host neutralizing responses and pathogenesis of hepatitis C virus infeetion显示文摘Zeisel M B Cosset F L Baumert T E 2008Hepatology2008,48,:1
10Performance modeling of the Ballard mark-IV solid polymer electrolyte fuel cell显示文摘J C Amphlett R M Baumert R F Mann B A Peppley P R Roberge T J Harries 1995Journal of electrochemical society1995,142,1:1
11miR - 122 acts as atumor suppressor in hepatocarcinogenesis in vivo 显示文摘ZEISEL M B PFEFFER S BAUMERT T F 2013J Hepatol2013,58,4:1
12Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression显示文摘Baumert T F Marrone A Vergalla J 1998J Virol1998,72,8:1
13Impact of microRNAs for pathogen-esis and treatment of hepatitis C virus infection显示文摘PFEFFERA S BAUMERT T F 0,,:1
14RNAi:a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle 显示文摘LUPBERGER J BRINO L BAUMERT T F 2008J Hepatol2008,48,3:1
15Performance modeling of the Ballard mark-IV solid polymer electrolyte fuel cell显示文摘J C Amphlett R M Baumert R F Mann Peppley B A Roberge P R Harries T J 1995Journal of the Electrochemical Society1995,142,1:1
16Two corepromotor mutations identified in a hepatitis B vims strainassociated with fulminant hepatitis result in enhanced viralreplication 显示文摘Baumert T F Rogers S A Hasegawa K 1996J Clin Invest1996,98,10:1
17A poxvirus vaccine is safe,induces T-cell responses, and decreases viral load inpatients with chronic hepatitis C显示文摘Habersetzer F Honnet G Bain C Maynard-Muet M Leroy V Zarski J P Feray C Baumert T F Bro- nowicki J P Doffoal M Trapo C Agathon D Toh M L Baudin M Bonnefoy J Y Limacher J M Inchausp: G 2011Gastroenterology2011,141,:1
18Hepatitis C virus structural proteins assemble into vimslike particles in insect cells 显示文摘BAUMERT T F ITO S WONG D T 1998J Virol1998,72,5:1
19Performance modelling of the ballard mark-Ⅳ solid polymer electrolyte fuel cell显示文摘J C Amphlett R M Baumert R F Mann B A Peppley P R Roberge T J Harries 1995Journal of the Electrochemical Society1995,142,1:1
20GI-5005,a yeast vector vaccine expressing an NS3-core fusion protein for chronic HCV infection显示文摘Habersetzer F Baumert T F Stoll-Keller F 2009Curr Opin Mol Ther2009,11,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费